TNFAIP6 and colitis: These results are consistent with those of our previous study, indicating that intraperitoneally injected cAT-MSCs formed aggregates in the peritoneal cavity and alleviated DSS-induced colitis at sites distant from the colon through soluble factors, such as TSG-6 [19].